2,3-dihydrobenzofuran-5YL compounds as DYRK kinase inhibitors

US10005769B2 · kind B2 · utility

Assignee

• 4SC AG · DE

Inventors

• Johann Leban · Planegg, DE
• Mirko Zaja · Birkenfeld, DE

Key dates

• Filing date: Jun 17, 2014
• Grant date: Jun 26, 2018
• Expiry date: Jun 17, 2034

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/02
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to compounds of below Formula (I), physiologically functional derivatives or salts thereof, where the groups R1, R2, R3, R4, RA, X1, and A, as well as the variables n, m and p are detailed further herein.